Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Omics-Based Development of Novel Thrombosis and Bleeding Markers and Construction of a Risk Prediction Model in Coronary Heart Disease

NCT07523880 is registered in ClinicalTrials.gov with Xueyan Zhao as lead sponsor.

NCT NCT07523880
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07523880 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Omics-Based Development of Novel Thrombosis and Bleeding Markers and Construction of a Risk Prediction Model in Coronary Heart Disease
Lead sponsor
Xueyan Zhao
Phase
Observational
Overall status
Recruiting
Start date
August 1, 2025
Completion date
July 31, 2029
Enrollment
12,154 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding, coronary artery disease (cad), thrombosis